GreenLight Biosciences
GRNA
Operating Margin for GreenLight Biosciences (GRNA)
Operating Margin at the end of 2020: -5,428.59%
According to GreenLight Biosciences's latest financial reports and stock price the company's current Operating Margin is -5,428.58%. At the end of 2020 the company had an Operating Margin of -5,428.59%.
Operating Margin history for GreenLight Biosciences from 2019 to 2020
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2020 | -5,428.59% | 475.01% |
| 2019 | -944.09% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.